C1IC34.SA Cigna Corporation
- Market cap
- BRL 435B
- P/E
- 12.8x
- P/B
- 1.88x
- ROE
- 15.6%
- Dividend yield
- 1.42%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is C1IC34.SA undervalued?
Graham numberC1IC34.SA trades 3.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cigna Corporation fundamental analysis
No fundamental analysis for Cigna Corporation yet.
Cigna Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cigna Corporation
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formu…
Full company profileCigna Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cigna Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 48.6B | 154B | 161B | 174B | 181B | 195B | 247B | 275B | 279B |
| Gross Profit | - | - | 24.0B | 23.0B | 23.5B | 25.2B | 26.0B | 25.6B | 25.1B |
| Operating Income | - | - | 12.3B | 7.99B | 10.1B | 7.04B | 9.26B | 9.21B | 9.12B |
| EBITDA | - | - | - | - | 12.6B | 9.99B | 9.48B | 12.0B | 13.1B |
| Net Income | 2.64B | 5.10B | 8.46B | 5.37B | 6.70B | 5.16B | 3.43B | 5.96B | 6.63B |
| EPS | 6.92 | 14 | 24 | 17 | 22 | 18 | 13 | 23 | 25 |
| Balance Sheet | |||||||||
| Total Assets | 153B | 156B | 155B | 155B | 144B | 153B | 156B | 158B | 157B |
| Total Liabilities | 112B | 110B | 105B | 108B | 99.2B | 106B | 115B | 116B | 114B |
| Shareholders' Equity | 41.0B | 45.3B | 50.3B | 47.1B | 44.7B | 46.2B | 41.0B | 41.7B | 42.6B |
| Cash & Short-term Investments | 3.86B | 4.62B | 11.5B | 6.00B | 6.83B | 8.75B | 8.22B | 8.73B | 6.30B |
| Cash Flow | |||||||||
| Operating Cash Flow | 3.77B | 9.49B | 10.4B | 7.19B | 8.66B | 11.8B | 10.4B | 9.60B | 1.42B |
| Capital Expenditure | 528M | 1.05B | 1.09B | 1.15B | 1.30B | 1.57B | 1.41B | 1.21B | 1.13B |
| Free Cash Flow | 3.24B | 8.44B | 9.26B | 6.04B | 7.36B | 10.2B | 8.96B | 8.39B | 292M |
| Ratios | |||||||||
| ROE | 6.4% | 11.3% | 16.8% | 11.4% | 15.0% | 11.2% | 8.4% | 14.3% | 15.6% |
| ROA | 1.7% | 3.3% | 5.4% | 3.5% | 4.7% | 3.4% | 2.2% | 3.8% | 4.2% |
| Net Profit Margin | 5.4% | 3.3% | 5.3% | 3.1% | 3.7% | 2.6% | 1.4% | 2.2% | 2.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Cigna Corporation dividends
- Dividend yield
- 1.42%
- Forward dividend
- 0.97 BRL
- Payout ratio
- 27.0%
- Ex-dividend date
- Dec 2, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 1.61B | 6.11 | 27.0% |
| 2024 | USD 1.57B | 5.72 | 45.6% |
| 2023 | USD 1.45B | 4.96 | 28.1% |
| 2022 | USD 1.38B | 4.63 | 20.6% |
| 2021 | USD 1.34B | 4.15 | 25.0% |
| 2020 | USD 15.0M | 0.04 | 0.2% |
| 2019 | BRL 15.0M | 0.04 | 0.3% |
| 2018 | BRL 15.0M | 0.04 | 0.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 6:1 on Aug 10, 2026.
Who owns Cigna Corporation
Ownership data of Cigna Corporation is not available yet.
Cigna Corporation company profile
- Company name
- Cigna Corporation
- Ticker
- C1IC34.SA
- Exchange
- Sao Paulo Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 65,669
- Fiscal year end
- December
- Address
- 900 Cottage Grove Road, Bloomfield, CT, United States, 06002
- Phone
- 860 226 6000
- Website
- thecignagroup.com
About Cigna Corporation
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Cigna Corporation management
10- Mr. David Michael CordaniExecutive Chairman of the Board · born 1965
- Mr. Brian Case Evanko C.F.A.President, CEO & Director · born 1977
- Ms. Ann M. DennisonExecutive VP & CFO · born 1971
- Ms. Nicole Susan Jones J.D.Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer · born 1971
- Mr. F. Everett NevilleExecutive VP & Special Advisor to the CEO · born 1965
- Ms. Jamie KatesSenior VP & Tax and Global Chief Accounting Officer · born 1980
- Mr. Durga Prasad KokaExecutive Vice President & Global Chief Information Officer
- Mr. Ralph GiacobbeSenior Vice President of Investor Relations
- Ms. Andrea NelsonEVP, General Counsel & Corporate Secretary
- Ms. Melissa SkottegaardExecutive Vice President, Chief Marketing & Communications Officer